Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
4.840
+1.310 (37.11%)
At close: Dec 20, 2024, 4:00 PM
4.870
+0.030 (0.62%)
After-hours: Dec 20, 2024, 7:11 PM EST
Elutia Employees
Elutia had 54 employees as of December 31, 2023. The number of employees decreased by 110 or -67.07% compared to the previous year.
Employees
54
Change (1Y)
-110
Growth (1Y)
-67.07%
Revenue / Employee
$458,926
Profits / Employee
-$1,003,741
Market Cap
167.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 54 | -110 | -67.07% |
| Dec 31, 2022 | 164 | -12 | -6.82% |
| Dec 31, 2021 | 176 | 13 | 7.98% |
| Dec 31, 2020 | 163 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| American Well | 1,104 |
| Akoya Biosciences | 330 |
| Protalix BioTherapeutics | 208 |
| Enanta Pharmaceuticals | 145 |
| Tenaya Therapeutics | 140 |
| Lineage Cell Therapeutics | 75 |
| PepGen | 64 |
| Black Diamond Therapeutics | 54 |
ELUT News
- 5 weeks ago - Elutia Inc. (ELUT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30 - GlobeNewsWire
- 3 months ago - Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company's Antibiotic-Eluting BioEnvelope for Implantable Devices - GlobeNewsWire
- 3 months ago - Elutia Celebrates First Year - GlobeNewsWire
- 3 months ago - Elutia Announces First Patient Implant of EluPro™, the World's First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators - GlobeNewsWire
- 3 months ago - Elutia to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire
- 4 months ago - Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript - Seeking Alpha